Ledger.Open graph →
SEC Form D · filed April 27, 2020

Claris Biotherapeutics, Inc

Offering
$26.0M
Sold
$11.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
JERSEY CITY, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Anton C. Atwell · Jersey City, NJExec · DirectorKenneth C. Harrison · Jersey City, NJDirectorReza C. Dana · Jersey City, NJDirectorVanessa Barrett · Grand Cayman, Cayman IslandsDirectorRichard Harris · NEW YORK, NYExec · DirectorShehzad Khan · NEW YORK, NYDirectorMark Floyd · Plano, TXDirectorSunriver Management LLC · Greenwich, CTDirectorSunriver GP LLC · Greenwich, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗